Graph
@graphtx.bsky.social
Improving the lives of patients with immune-mediated diseases. We combine complex primary disease models with advanced ML to bridge the gap between pre-clinical models & clinical applications.
🌐 graphtx.com
✏️ graphtx.substack.com
🌐 graphtx.com
✏️ graphtx.substack.com
Thank you to everyone who attended our AI x Bio meetup last week in Berlin! We had a great time catching up with old friends and making new connections. 🪩 🕺
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
November 26, 2025 at 1:48 PM
Thank you to everyone who attended our AI x Bio meetup last week in Berlin! We had a great time catching up with old friends and making new connections. 🪩 🕺
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
👏 A huge thank you to all of our cohosts, including @Merantix AI Campus, Merantix Capital, CytoData, and @techbio.bsky.social support!
Immune-mediated diseases are highly complex and heterogeneous, which makes the discovery of precision medicines difficult. In Graph’s most recent poster at #CytoData2025, our research team showcased our systematic approach to address this challenge. 🎯
November 21, 2025 at 10:47 AM
Immune-mediated diseases are highly complex and heterogeneous, which makes the discovery of precision medicines difficult. In Graph’s most recent poster at #CytoData2025, our research team showcased our systematic approach to address this challenge. 🎯
Hey Berlin, we’ll be in town from 20 - 21 November for CytoData 2025! If you want to know more about how we are decoding the functional and molecular niche of immune-mediated diseases for iterative target discovery, come by our poster session to learn more!
November 10, 2025 at 10:26 AM
Hey Berlin, we’ll be in town from 20 - 21 November for CytoData 2025! If you want to know more about how we are decoding the functional and molecular niche of immune-mediated diseases for iterative target discovery, come by our poster session to learn more!
Meet the team behind Graph and say hello to @izepb.bsky.social, Principal Scientist! 🧬⛰️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
October 28, 2025 at 8:02 AM
Meet the team behind Graph and say hello to @izepb.bsky.social, Principal Scientist! 🧬⛰️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
Ize is helping us scale new heights where ML meets biology, one complex system at a time. ➕✖️
✨ Some exciting news: We’re announcing a strategic partnership with the Botnar Institute of Immune Engineering (BIIE) to accelerate the development of precision medicines for immune-mediated diseases!
October 7, 2025 at 9:05 PM
✨ Some exciting news: We’re announcing a strategic partnership with the Botnar Institute of Immune Engineering (BIIE) to accelerate the development of precision medicines for immune-mediated diseases!
Meet the Graph team at #BIOEurope in Vienna from 3 - 5 November! We’ll be sharing how Graph is leading the way towards precision immunology drug discovery and development through capturing, mapping, and predicting patient immune dysfunction at scale.
October 2, 2025 at 10:00 AM
Meet the Graph team at #BIOEurope in Vienna from 3 - 5 November! We’ll be sharing how Graph is leading the way towards precision immunology drug discovery and development through capturing, mapping, and predicting patient immune dysfunction at scale.
Meet the team behind Graph and say hello to Desy Vallorani, Research Associate! 🚢🔬
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
September 30, 2025 at 8:04 AM
Meet the team behind Graph and say hello to Desy Vallorani, Research Associate! 🚢🔬
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
With Desy’s help, we’re generating high-quality and contextually rich datasets for complex immune diseases. ➕✖️
Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬
September 22, 2025 at 6:59 AM
Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬
@gregvladimer.bsky.social, Aishwarya Parthasarathy, Nathan Benaich, and @georgwinter.bsky.social wrapped up the final session of the @aithyra.bsky.social symposium with a panel discussion about building AI-first spinouts and ventures, and how to improve science & tech collaborations. 🚀✨
September 10, 2025 at 2:02 PM
@gregvladimer.bsky.social, Aishwarya Parthasarathy, Nathan Benaich, and @georgwinter.bsky.social wrapped up the final session of the @aithyra.bsky.social symposium with a panel discussion about building AI-first spinouts and ventures, and how to improve science & tech collaborations. 🚀✨
Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕
September 8, 2025 at 9:27 AM
Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕
Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
August 27, 2025 at 2:33 PM
Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️
Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬
August 4, 2025 at 1:20 PM
Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬
Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
July 18, 2025 at 2:11 PM
Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️
Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️
June 30, 2025 at 11:52 AM
Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️
Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
May 26, 2025 at 1:10 PM
Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️
Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬
April 24, 2025 at 8:24 AM
Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬
Hey Singapore, @kdris.bsky.social will be at ICLR 2025 from 24 - 28 April! We’re looking forward to hearing about the latest discoveries in biology, AI, and deep learning. Let us know if you’ll be around! 🇸🇬
April 22, 2025 at 9:13 AM
Hey Singapore, @kdris.bsky.social will be at ICLR 2025 from 24 - 28 April! We’re looking forward to hearing about the latest discoveries in biology, AI, and deep learning. Let us know if you’ll be around! 🇸🇬
📣 Congratulations to Graph scientific co-founder Berend Snijder on his new appointment as Faculty Professor and Research Group Leader at the Botnar Institute of Immune Engineering (BIIE)! Here’s to even more groundbreaking work and discoveries. 🥂💥
➡️ Read more: immune.engineering/news/dr-bere...
➡️ Read more: immune.engineering/news/dr-bere...
March 26, 2025 at 3:51 PM
📣 Congratulations to Graph scientific co-founder Berend Snijder on his new appointment as Faculty Professor and Research Group Leader at the Botnar Institute of Immune Engineering (BIIE)! Here’s to even more groundbreaking work and discoveries. 🥂💥
➡️ Read more: immune.engineering/news/dr-bere...
➡️ Read more: immune.engineering/news/dr-bere...
¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋
March 24, 2025 at 10:10 AM
¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋
We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
March 18, 2025 at 2:35 PM
We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
@gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏
Graph has been awarded an Austrian Life Sciences grant worth EUR 1.1M from the FFG (Austrian Research Promotion Agency)! This funding helps us continue to develop our lab-in-the-loop AI-driven approach to discover better therapeutics for immune-mediated diseases. 🔬🚀
March 3, 2025 at 3:59 PM
Graph has been awarded an Austrian Life Sciences grant worth EUR 1.1M from the FFG (Austrian Research Promotion Agency)! This funding helps us continue to develop our lab-in-the-loop AI-driven approach to discover better therapeutics for immune-mediated diseases. 🔬🚀
Anyone around Milan 🇮🇹 from 17 - 19 March? We’ll be there! Come and say Ciao! to our CEO & cofounder @gregvladimer.bsky.social and connect with us at BIO-Europe Spring!
February 27, 2025 at 9:18 AM
Anyone around Milan 🇮🇹 from 17 - 19 March? We’ll be there! Come and say Ciao! to our CEO & cofounder @gregvladimer.bsky.social and connect with us at BIO-Europe Spring!
🔬🧬 AI x bio arrives in Paris! Come say Salut! to Graph's @kdris.bsky.social & the techbio community for the @techbio.bsky.social x @bitsinbio.bsky.social meetup, co-hosted with ORAKL Oncology, Speedinvest, & BioLabs. 25 Feb @ 18:30. Join the waitlist: lu.ma/3vavwseg
February 17, 2025 at 7:48 AM
🔬🧬 AI x bio arrives in Paris! Come say Salut! to Graph's @kdris.bsky.social & the techbio community for the @techbio.bsky.social x @bitsinbio.bsky.social meetup, co-hosted with ORAKL Oncology, Speedinvest, & BioLabs. 25 Feb @ 18:30. Join the waitlist: lu.ma/3vavwseg
Graph Therapeutics announces the closing of a $3.1M pre-seed round aimed at bringing the precision medicine paradigm to inflammation and immunology (I&I). 🚀🔬🧬
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...
January 10, 2025 at 8:32 PM
Graph Therapeutics announces the closing of a $3.1M pre-seed round aimed at bringing the precision medicine paradigm to inflammation and immunology (I&I). 🚀🔬🧬
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...
Looking forward to great things to come!
Read more ➡️ graphtx.com/news#graph-p...